We are live on
!
Find out more
EPGL
Evelyn Partners Group Ltd Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AstraZeneca
AZN
$250B
| $41.5B | 88.6% |
+2,237,205
| New | +$421M |
|
|
2
Alphabet (Google) Class A
GOOGL
$4.33T
| $406M | 0.87% |
+1,135,205
| New | +$409M |
|
|
3
Amazon
AMZN
$2.96T
| $375M | 0.8% |
+1,573,537
| New | +$395M |
|
|
4
Microsoft
MSFT
$3.71T
| $348M | 0.74% |
+934,190
| New | +$378M |
|
5
TSMC
TSM
$2.18T
| $268M | 0.57% |
+561,594
| New | +$228M |
|
|
6
NVIDIA
NVDA
$5.42T
| $254M | 0.54% |
+1,269,050
| New | +$261M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.13T
| $195M | 0.42% |
+389,406
| New | +$187M |
|
8
Apple
AAPL
$4.57T
| $178M | 0.38% |
+616,120
| New | +$176M |
|
9
Visa
V
$677B
| $175M | 0.37% |
+509,067
| New | +$163M |
|
10
CRH
CRH
$66.8B
| $145M | 0.31% |
+1,354,624
| New | +$149M |
|
11
Chubb
CB
$135B
| $125M | 0.27% |
+366,014
| New | +$119M |
|
12
Stryker
SYK
$130B
| $125M | 0.27% |
+396,034
| New | +$125M |
|
13
JPMorgan Chase
JPM
$950B
| $117M | 0.25% |
+357,839
| New | +$111M |
|
14
Meta Platforms (Facebook)
META
$1.51T
| $102M | 0.22% |
+181,201
| New | +$111M |
|
15
Coca-Cola
KO
$375B
| $90.8M | 0.19% |
+1,116,793
| New | +$88.2M |
|
16
Broadcom
AVGO
$2.04T
| $80.8M | 0.17% |
+213,925
| New | +$85.8M |
|
17
Johnson & Johnson
JNJ
$625B
| $75.6M | 0.16% |
+297,561
| New | +$69.3M |
|
18
Goldman Sachs
GS
$303B
| $70.4M | 0.15% |
+69,625
| New | +$67.9M |
|
19
Mastercard
MA
$493B
| $68.7M | 0.15% |
+133,786
| New | +$66.7M |
|
20
Amphenol
APH
$209B
| $64.5M | 0.14% |
+365,938
| New | +$52.8M |
|
21
Thermo Fisher Scientific
TMO
$220B
| $58.8M | 0.13% |
+117,349
| New | +$56.3M |
|
22
IDEX
IEX
$17.3B
| $56.9M | 0.12% |
+250,896
| New | +$53.1M |
|
23
SPDR Gold Trust
GLD
$141B
| $53.2M | 0.11% |
+144,360
| New | +$59.8M |
|
|
24
Alphabet (Google) Class C
GOOG
$4.32T
| $52.5M | 0.11% |
+148,484
| New | +$53.1M |
|
25
NextEra Energy
NEE
$177B
| $51.8M | 0.11% |
+590,293
| New | +$53.4M |
|
Similar funds
TI
LP
Evelyn Partners Group Ltd's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners Group Ltd, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners Group Ltd's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners Group Ltd's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners Group Ltd disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.